Clinical Trial: Comprehensive Oncology Measures for Peripheral T-cell Lymphoma Treatment Registry
Study Status: Active, not recruiting
Recruit Status: Active, not recruiting
Study Type: Observational
Official Title: Prospective, Longitudinal, Multinational Registry of Patients With Newly Diagnosed Peripheral T-Cell Lymphoma
Brief Summary: The COMPLETE registry is a prospective, longitudinal, multinational, observational study that will collect data on how patients with peripheral T-cell lymphoma (PTCL) are treated in academic and community practices. The registry will enroll newly-diagnosed patients with PTCL treated with a variety of regimens. The COMPLETE registry is designed to better understand PTCL patient characteristics, treatments, and outcomes to help design and understand future clinical trials.
Detailed Summary:
Sponsor: Spectrum Pharmaceuticals, Inc
Current Primary Outcome:
Original Primary Outcome:
Current Secondary Outcome:
Original Secondary Outcome:
Information By: Spectrum Pharmaceuticals, Inc
Dates:
Date Received: April 23, 2010
Date Started: February 2010
Date Completion: February 2019
Last Updated: July 20, 2016
Last Verified: July 2016